Related Experiment Video
Updated: Apr 19, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Transforming cardiovascular disease prevention in women: time for the Pygmalion construct to end
1Emory University School of Medicine, and Emory Heart and Vascular Center, Atlanta, Ga., USA.
Abstract:
The transformation of cardiovascular disease prevention for women must address that a number of nontraditional atherosclerotic cardiovascular disease risk factors are unique to or predominant in women. As well, many traditional atherosclerotic cardiovascular disease risk factors impart differential risks for women and for men. Gender-specific risk assessment and management have the potential to improve atherosclerotic cardiovascular disease outcomes in women.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Cancer Prevention
Some...
Cancer Prevention
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction

